Who owns Seres Therapeutics Inc?
- Ticker: MCRB
- CUSIP Number: 81750r201
Tip: Access positions for across all investors
Analyze quarterly positions in Seres Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seres Therapeutics stock
Who bought or sold Seres Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Flagship Ventures Management | 1.2M | $9.1M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 288k | $2.3M | -2% | Jun 2026 |
|
| Marshall Wace | 172k | $1.4M | 23% | Jun 2026 |
|
| Susquehanna International | 133k | $1.1M | -41% | Jun 2026 |
|
| Vontobel Holding | 123k | $970k | -11% | Jun 2026 |
|
| BlackRock | 111k | $876k | 9% | Jun 2026 |
|
| Geode Capital Management | 80k | $631k | 7% | Jun 2026 |
|
| Citadel Advisors | 54k | $426k | -9% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 49k | $384k | 23% | Jun 2026 |
|
| State Street Corporation | 34k | $301k | 0% | Mar 2026 |
|
| Lion Point Capital | 32k | $249k | 0% | Jun 2026 |
|
| Charles Schwab Investment Management | 31k | $245k | -2% | Jun 2026 |
|
| Sixth Street Partners Management Company | 31k | $245k | 100% | Jun 2026 |
|
| American Century Companies | 28k | $223k | -55% | Jun 2026 |
|
| Morgan Stanley | 22k | $193k | -14% | Mar 2026 |
|
| XTX Topco | 21k | $164k | 100% | Jun 2026 |
|
| Goldman Sachs Group | 15k | $120k | 100% | Jun 2026 |
|
| Northern Trust | 15k | $117k | 0% | Jun 2026 |
|
| Invesco | 13k | $102k | -11% | Jun 2026 |
|
| Simplex Trading | 4.6k | $36k | 50% | Jun 2026 |
|
| SBI Securities | 4.2k | $33k | 20% | Jun 2026 |
|
| Integrated Wealth Concepts | 4.0k | $32k | 100% | Jun 2026 |
|
| Group One Trading | 3.7k | $29k | 351% | Jun 2026 |
|
| Jpmorgan Chase & Co | 3.6k | $28k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 2.0k | $16k | 0% | Jun 2026 |
|
| FMR | 1.5k | $12k | -13% | Jun 2026 |
|
| Rachor Investment Advisory Services | 1.5k | $12k | 0% | Jun 2026 |
|
| UBS Group | 484.00 | $3.8k | -93% | Jun 2026 |
|
| Tower Research Capital | 316.00 | $2.5k | -60% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 211.00 | $1.7k | 0% | Jun 2026 |
|
| Barclays | 167.00 | $1.3k | -97% | Jun 2026 |
|
| Continuum Advisory | 47.00 | $370.999200 | 100% | Jun 2026 |
|
| Mercer Global Advisors | 37.00 | $292.000300 | 100% | Jun 2026 |
|
| Royal Bank of Canada | 11.00 | $0 | -90% | Jun 2026 |
|
| Wells Fargo & Company | 10.00 | $79.000000 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 8.00 | $63.000000 | 0% | Jun 2026 |
|
| Larson Financial Group | 5.00 | $39.000000 | 100% | Jun 2026 |
|
| Whittier Trust Co. of Nevada | 1.00 | $8.000000 | 100% | Jun 2026 |
|
Who sold out of Seres Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Mar 2026 | 19k | $167k |
| UMA Financial Services | Mar 2026 | 142.00 | $1.3k |
| Sound Income Strategies | Mar 2026 | 8.00 | $71.000000 |
| SRS Capital Advisors | Mar 2026 | 6.00 | $18.000000 |
| Hanson McClain Advisors | Mar 2026 | 4.00 | $36.000000 |